Medical device marketing translation risks: how to safeguard your content and compliance

Translating a brochure, landing page or launch campaign for a medical device is about much more than language. Marketing content must be compelling without compromising accuracy, fairness, supporting evidence or consistency with the device’s intended purpose, CE marking (European conformity), clinical evidence and the rules applicable to the target market.

The risks associated with medical device marketing translation are becoming increasingly significant. Overly persuasive wording, a poorly conveyed nuance or an expanded claim can turn content that is acceptable in the source language into a problematic message in the target language. In a sector where advertising is regulated, a translation error can become a risk to regulatory compliance, reputation and, in some cases, user safety.

Why medical device marketing content is more exposed to risks

Marketing content sits at the boundary between information and promotion. Promotional content seeks to highlight a benefit, simplify a message or create engagement.

Advertising for medical devices is subject to specific requirements: it covers any form of information, promotional activity or inducement aimed at promoting the prescription, supply, sale or use of a device. Labels, instructions for use, certain non-promotional communications and certain information relating to medical device vigilance are excluded from this definition, but many types of marketing content may fall within the scope of advertising. For further clarification, it is useful to consult Article 7 of the EU Medical Device Regulation (MDR).

The risk arises when the translation alters the balance of the message. For example, “helps support” can become “guarantees”, “may improve” can become “improves”, or an indication limited to a specific user profile may be rendered as a general promise.

What are the marketing translation risks for medical devices?

The first risk is a misleading claim. Medical device advertising must objectively define the device, its performance and its compliance, promote its proper use and not mislead the user or patient. This is in line with Article 7 of Regulation (EU) 2017/745, which sets requirements for claims concerning a device’s intended purpose, safety and performance. This makes the applicable regulatory requirements an essential reference point for marketing teams.

The second risk is inconsistency across different materials. A campaign may include a web page, an email, a brochure, a video, a webinar script, distributor materials and LinkedIn posts. If each item is translated separately, the terminology and levels of claims may vary.

The third risk is cultural. A message that is acceptable in one market may seem too direct, too commercial or insufficiently cautious in another. An effective marketing translation should not simply sound natural; it must remain proportionate.

As we explained in our article on marketing translation, adapting a message to the target market is just as important as preserving its meaning.

Understanding medical device advertising requirements

Medical device advertising is not subject to a single regulatory regime. According to the European Commission, requirements for medical device advertising may vary depending on factors such as the target audience, the type of device and its risk classification. Depending on the applicable regulatory framework, some advertising may be subject to review after publication, while other materials may require prior approval. The detailed requirements are set out in the applicable regulatory framework, including Article 7 of the EU Medical Device Regulation (MDR).

Where a marketing material is subject to regulatory review, each claim in the translated version should be traceable to the relevant supporting documentation, including the instructions for use, labelling, publications, assessments and performance evidence. For materials subject to regulatory review, the submission should include the proposed advertisement and supporting documentation for the claims. Materials forming part of the same campaign for the same device should also be submitted together where possible. The applicable procedure depends on the regulatory requirements of the target market. For the EU,  Article 7 of Regulation (EU) 2017/745 sets out requirements concerning claims made in medical device advertising. .

Where can translation errors creep in?

A translation error is not limited to choosing the wrong medical term. It can affect the strength of a sentence, the scope of a benefit or the relationship between benefit and risk.

The most sensitive areas are as follows:

• campaign headlines;
• slogans;
• product benefits;
• comparisons with other solutions;
• testimonials;
• calls to action;
• performance descriptions;
• messages intended for patients;
• social media posts and sponsored content;
• video or audio scripts.

A statement such as “designed to help clinicians visualise more effectively” does not have the same scope as “enables clinicians to visualise more effectively”. The second version may sound more natural, but it makes a stronger assertion. This type of nuance must be reviewed by a specialised linguist and, ideally, by the regulatory or medical teams.

Social media and digital content: increased vigilance

In an article published by Taylor Wessing, the author highlights the need for particular vigilance when advertising has a cross-border reach, while open social media platforms create specific risks through comments, shares and other interactions that may be difficult to control. You can read this analysis on medical device advertising requirements in Europe here.

Manufacturers and distributors of healthcare products should assess whether their communication is informational or promotional and consider the audience it is intended for. The CMS Expert Guide on advertising of medicines and medical devices also highlights the particular challenges of advertising healthcare products through social media, where requirements can vary significantly between jurisdictions.

Marketing translation, compliance and documentary consistency

A marketing campaign does not exist in isolation. It must remain aligned with the product documentation, intended purpose, information provided by the manufacturer and the language requirements applicable in each Member State.

The European Commission provides tables designed to help manufacturers understand the language requirements applicable to information and instructions accompanying devices in each country. These tables also cover certain aspects relating to graphical interfaces, such as those used in software and applications. The European guidance on language requirements for medical device manufacturers can therefore help manufacturers anticipate their multilingual requirements.

For marketing teams, maintaining this consistency requires close collaboration with QARA, medical and product teams. A translated campaign must be consistent with the IFU, labelling, technical documentation, approved messages and limitations on use. This is where medical device translation and marketing translation need to work together rather than as two separate workflows.

Implementing a secure marketing translation process

A good workflow begins before translation. The first step is to identify the status of the content: corporate information, educational content, sales material, regulated advertising, content intended for healthcare professionals or content accessible to the general public.

Teams should then prepare the language resources: an approved glossary, translation memory, list of approved claims and prohibited wording. Quality standards can also provide a framework. The ISO 17100 standard for translation services sets out requirements for the processes, resources and other aspects necessary to provide a quality translation service.

Finally, the review process should be tailored to the content. The intended meaning, claim, clinical scope, consistency with the supporting evidence and perception among the target audience should all be checked. Specialised medical translation can ensure consistent terminology, but promotional content also requires marketing and regulatory expertise.

How to reduce risk before publication

The best approach is to integrate translation into the validation process rather than treating it as a final step.

Before publication, it is useful to check five key points:

1. Does the translated claim accurately reflect the approved source claim?
2. Is the stated benefit proportionate to the available evidence?
3. Is the target audience clearly identified?
4. Is the material consistent with the IFU, labelling and regulatory claims?
5. Have the creative adaptations been approved by the appropriate people?

This review should be documented. In a regulated environment, traceability is just as important as the visible quality of the text. It should be possible to document who translated the content, who reviewed it, which resources were used and what decisions were made.

Conclusion: persuasive translation without compromising compliance

Managing the risks associated with medical device marketing translation requires more than linguistic expertise. It requires an understanding of regulations, marketing practices, the limits of claims, target audiences and the constraints specific to digital channels.

A successful translation does more than simply make the text easier to read. It protects the consistency of the message, the credibility of the brand and regulatory compliance. For sensitive content, working with a translation agency specialising in medical devices, marketing content and validation workflows can help your teams move forward with greater peace of mind, without losing the impact of your campaigns.